Bionano Genomics, Inc.
BNGO- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001411690
In the last 90 days, Bionano Genomics, Inc. insiders filed 2 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q3 2026, worth $4.21M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 17, 2026
- $13.3M
- Insider buysLast 90 days, $9.70K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +1 vs. previous quarter
- 35
- 13F valueReported value at the end of Q3 2026
- $4.21M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $28.5M
- −7.4% year over year
- Net income, FY2025
- -$26.4M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $8.28M
- +12.3% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $26.4M (92.6% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.39M
- Shares sold short
- Change
- +27.6K
- +2.0% vs. previous
- Days to cover
- 7.39
- At average daily volume
Superinvestors holding BNGO, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding BNGO at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Bionano Genomics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)4:30 PM ET | Sep 4 | 5 days | Luderer AlbertInterim Chief Executive | PPurchase | +4.00K | $1.21 | +$4.84K | +100.0%8.00K after | |
| Aug 21, 2026 (view filing)4:30 PM ET | Aug 21 | Same day | Luderer AlbertInterim Chief Executive | PPurchase | +4.00K | $1.22 | +$4.86K | New position4.00K after | |
| Jun 14, 2023 (view filing) | Jun 13 | 1 day | Mamuszka HannahDirector | PPurchase | +65.8K | $0.76 | +$50.0K | New position65.8K after | |
| May 16, 2023 (view filing) | May 16 | Same day | Holmlin R. ErikPresident and CEO | PPurchase | +15.0K | $0.64 | +$9.60K | +1.9%806.5K after | |
| May 16, 2023 (view filing) | May 12 | 4 days | Stewart Christopher P.Chief Financial Officer | PPurchase | +50.0K | $0.67 | +$33.5K | +21.6%281.4K after | |
| Aug 17, 2022 (view filing)5:55 PM ET | Aug 15 | 2 days | Linney YvonneDirector | SSale | −20.0K | $3.62 | −$72.4K | −100.0%0 after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Barker David LDirector | PPurchase | +10.0K | $1.60 | +$16.0K | +256.8%13.9K after | |
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Holmlin R. ErikPresident and CEO | PPurchase | +5.03K | $3.99 | +$20.0K | New position5.03K after | 3 lots |
Top 10 13F holders, Q3 2026
See all 35 holdersThe largest institutional positions in Bionano Genomics, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 1,165,000 | $1.82M | 0.21% | +1,165,000 | New |
| Two Sigma Investments, LP | 483,557 | $754.3K | 0.00% | +483,557 | New |
| Renaissance Technologies LLC | 154,000 | $240.2K | 0.00% | +102,900+201.4% | Added |
| Vanguard Capital Management LLC | 138,786 | $216.5K | 0.00% | +56,398+68.5% | Added |
| Carret Asset Management, LLC | 135,545 | $211.4K | 0.02% | +10,545+8.4% | Added |
| HRT Financial LP | 96,866 | $151.0K | 0.00% | +85,126+725.1% | Added |
| Gsa Capital Partners LLP | 92,384 | $144.0K | 0.01% | −57,900−38.5% | Reduced |
| Acadian Asset Management LLC | 89,186 | $137.0K | 0.00% | +89,186 | New |
| Jane Street Group, LLC | 86,321 | $134.7K | 0.00% | +50,593+141.6% | Added |
| Geode Capital Management, LLC | 77,274 | $120.5K | 0.00% | −12,719−14.1% | Reduced |
Holders of 5% or more of BNGO
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Bionano Genomics, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 13G | 9.99%528.2K shares | New | Nov 13, 20251 filing | Nov 13, 2025 | SEC |
| CVI Investments, Inc. | 13G/A | 9.90%1.50M shares | 0.00 ppfrom 9.90% | Jan 13, 20256 filings | Nov 16, 2026 | SEC |
| Hirschman Orin | 13G | 9.90%1.17M shares | New | Oct 19, 20261 filing | Oct 19, 2026 | SEC |
| Lind Global Fund III LP | 13G/A | 9.35%1.05M shares | −0.55 ppfrom 9.90% | Sep 24, 20253 filings | Feb 17, 2026 | SEC |
| Lincoln Alternative Strategies LLC | 13G | 5.42%525.0K shares | New | Sep 17, 20251 filing | Sep 17, 2025 | SEC |